MESNEX (Baxter Healthcare Corporation)
Welcome to the PulseAid listing for the MESNEX drug offered from Baxter Healthcare Corporation. This Cytoprotective Agent [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Baxter Healthcare Corporation |
NON-PROPRIETARY NAME: | mesna |
SUBSTANCE NAME: | MESNA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cytoprotective Agent [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | INJECTION, SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 1988-12-30 |
END MARKETING DATE: | 0000-00-00 |
MESNEX HUMAN PRESCRIPTION DRUG Details:
Item Description | MESNEX from Baxter Healthcare Corporation |
LABELER NAME: | Baxter Healthcare Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/mL) |
START MARKETING DATE: | 1988-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0338-1305_22dd9d12-b425-454f-9835-a0807595acdd |
PRODUCT NDC: | 0338-1305 |
APPLICATION NUMBER: | NDA019884 |
Other MESNA Pharmaceutical Manufacturers / Labelers: